Literature DB >> 16229803

Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues.

Liang Zhou1, Weihong Jiang, Caiping Ren, Zhihua Yin, Xiangling Feng, Weidong Liu, Qian Tao, Kaitai Yao.   

Abstract

We examined the promoter hypermethylation of tumor-suppressor genes RASSF1A and TSLC1, quantitated EBV DNA load in nasopharyngeal carcinoma (NPC) tissues (T tissues), and matched tumor-adjacent tissues outside 0.5 cm (P tissues) and outside 1.0 cm (Z tissues) to evaluate the role of promoter hypermethylation of RASSF1A and TSLC1 as well as viral load in the pathogenesis of NPC. Methylation-specific polymerase chain reaction (PCR) for RASSF1A and TSLC1 and quantitative real-time PCR analysis of EBV DNA were performed on matched T, P, and Z tissues (n = 28) as well as chronic nasopharyngitis tissues (n = 8). Hypermethylated RASSF1A was frequently detected in the T (82%) and P tissues (75%), but less frequently in Z tissues (46%). he average quantities of EBV DNA (copies/microg DNA) in matched T, P, and Z tissues were 673,000, 90,000, and 7000. The differences of promoter hypermethylation of RASSF1A and EBV viral load among T, P, and Z tissues were statistically significant, with more frequent methylation and higher viral load detected when tissues examined were nearer to the NPC tissues. Our results suggest that aberrant hypermethylation of RASSF1A and high EBV load might be important events in NPC pathogenesis, and they may be useful molecular diagnostic markers for this cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16229803      PMCID: PMC1501935          DOI: 10.1593/neo.05217

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  21 in total

1.  Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.

Authors:  Y M Lo; L Y Chan; K W Lo; S F Leung; J Zhang; A T Chan; J C Lee; N M Hjelm; P J Johnson; D P Huang
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

2.  High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.

Authors:  K W Lo; J Kwong; A B Hui; S Y Chan; K F To; A S Chan; L S Chow; P M Teo; P J Johnson; D P Huang
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

3.  Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.

Authors:  Joseph Kwong; Kwok-Wai Lo; Ka-Fai To; Peter M L Teo; Philip J Johnson; Dolly Poon Huang
Journal:  Clin Cancer Res       Date:  2002-01       Impact factor: 12.531

4.  Detailed deletion mapping on the short arm of chromosome-3 in nasopharyngeal carcinomas.

Authors:  K Lo; S Tsao; S Leung; P Choi; J Lee; D Huang
Journal:  Int J Oncol       Date:  1994-06       Impact factor: 5.650

5.  Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma.

Authors:  D P Huang; K W Lo; P H Choi; A Y Ng; S Y Tsao; G K Yiu; J C Lee
Journal:  Cancer Genet Cytogenet       Date:  1991-07-01

6.  A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma.

Authors:  D P Huang; K W Lo; C A van Hasselt; J K Woo; P H Choi; S F Leung; S T Cheung; P Cairns; D Sidransky; J C Lee
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

7.  Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination.

Authors:  M Andersson-Anvret; N Forsby; G Klein; W Henle
Journal:  Int J Cancer       Date:  1977-10-15       Impact factor: 7.396

8.  Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.

Authors:  Luke Hesson; Ivan Bièche; Dietmar Krex; Emmanuelle Criniere; Khê Hoang-Xuan; Eamonn R Maher; Farida Latif
Journal:  Oncogene       Date:  2004-03-25       Impact factor: 9.867

9.  RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.

Authors:  Lillian Shuk-Nga Chow; Kwok-Wai Lo; Joseph Kwong; Ka-Fai To; Kam-Sze Tsang; Ching-Wan Lam; Reinhard Dammann; Dolly P Huang
Journal:  Int J Cancer       Date:  2004-05-10       Impact factor: 7.396

10.  High sensitivity mapping of methylated cytosines.

Authors:  S J Clark; J Harrison; C L Paul; M Frommer
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

View more
  29 in total

1.  An update on Epstein-Barr virus and nasopharyngeal carcinogenesis.

Authors:  Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2007-12-01

Review 2.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

Review 3.  Epstein-Barr virus: a master epigenetic manipulator.

Authors:  Rona S Scott
Journal:  Curr Opin Virol       Date:  2017-08-04       Impact factor: 7.090

4.  Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis.

Authors:  Paul G Murray; Yichao Fan; Gillian Davies; Jianming Ying; Hua Geng; Ka Man Ng; Hongyu Li; Zifen Gao; Wenbin Wei; Shikha Bose; Jennifer Anderton; Georgia Kapatai; Gary Reynolds; Akihiko Ito; Teresa Marafioti; Ciaran Bj Woodman; Richard Ambinder; Qian Tao
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

5.  Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.

Authors:  Abhik Saha; Hem C Jha; Santosh K Upadhyay; Erle S Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

6.  Nasopharyngeal carcinoma: the role of the Epstein-Barr virus.

Authors:  Eugene A Chu; Julie M Wu; David E Tunkel; Stacey L Ishman
Journal:  Medscape J Med       Date:  2008-07-16

Review 7.  Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.

Authors:  André Nogueira da Costa; Zdenko Herceg
Journal:  Mol Oncol       Date:  2012-08-16       Impact factor: 6.603

8.  Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma.

Authors:  Dong Liu; Xianjun Feng; Xinjun Wu; Zhanguo Li; Wanling Wang; Yipeng Tao; Yonghua Xia
Journal:  Tumour Biol       Date:  2013-06-30

9.  Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.

Authors:  Hendrik Andreas Wolff; Ralph M W Rödel; Bastian Gunawan; Tobias Overbeck; Markus K A Herrmann; Steffen Hennies; Andrea Hille; Hilke Vorwerk; Christoph Matthias; Clemens F Hess; Hans Christiansen
Journal:  J Cancer Res Clin Oncol       Date:  2009-07-18       Impact factor: 4.553

10.  Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.

Authors:  Minghua Wu; Xiayu Li; Xiaoling Li; Guiyuan Li
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.